Related Experiment Videos
Use of fluorocitrate and fluoroacetate in the study of brain metabolism
F Fonnum1, A Johnsen, B Hassel
1Norwegian Defence Research Establishment, Division for Environmental Toxicology, Kjeller.
Abstract:
Fluoroacetate and its toxic metabolite fluorocitrate cause inhibition of aconitase. In brain tissue, both substances are preferentially taken up by glial cells and leads to inhibition of the glial TCA cycle. It is important to realise, however, that the glia-specificity of these compounds depends both on the dosage and on the model used. The glia-inhibitory effect of fluorocitrate as obtained by intracerebral microinjection in vivo is reversible within 24 h. A substantial inhibition of the glial TCA cycle by systemic administration of fluoroacetate requires a lethal dose. Inhibition of the glial aconitase leads to accumulation of citrate and to a reduction in the formation of glutamine. Whereas the former is likely to be responsible for the main toxic effect of these compounds possibly by chelation of free calcium ions, it is the latter that has received most attention in the study of glial-neuronal interactions, since glutamine is an important precursor for transmitter glutamate and GABA.
Insights
Fluoroacetate and fluorocitrate disrupt glial cell metabolism by inhibiting aconitase and the TCA cycle. This affects neurotransmitter precursor formation, impacting glial-neuronal interactions.
Area of Science:
- Neuroscience
- Biochemistry
- Toxicology
Background:
- Fluoroacetate and its metabolite fluorocitrate are known inhibitors of aconitase.
- Glial cells are preferential targets for these compounds in brain tissue.
- Inhibition of the glial TCA cycle has implications for neuronal function.
Purpose of the Study:
- To investigate the glia-specific effects of fluoroacetate and fluorocitrate.
- To understand the impact of glial TCA cycle inhibition on neurotransmitter metabolism.
- To elucidate the mechanisms of toxicity and glial-neuronal interactions.
Main Methods:
- In vivo studies using intracerebral microinjection and systemic administration.
- Analysis of glial cell uptake and metabolic effects.
- Measurement of aconitase activity, TCA cycle intermediates, and glutamine formation.
Main Results:
- Fluorocitrate causes reversible glial inhibition within 24 hours post-microinjection.
- Systemic fluoroacetate requires lethal doses for substantial glial TCA cycle inhibition.
- Inhibition leads to citrate accumulation and reduced glutamine synthesis.
Conclusions:
- Glia-specific toxicity of fluoroacetate/fluorocitrate is dose- and model-dependent.
- Citrate accumulation may contribute to the primary toxic effects.
- Reduced glutamine synthesis impacts neurotransmitter precursor availability for neuronal signaling.